Unilateral injection of Aβ25-35 in the hippocampus reduces the number of dendritic spines in hyperglycemic rats

Synapse

Volumn 68, Issue 12, 2014, Pages 585-594

  Lazcano, Zayda ^a   Solis, Oscar ^a   Bringas, María Elena ^a   Limón, Daniel ^a   Diaz, Alfonso ^a,b,c   Espinosa, Blanca ^d   García Peláez, Isabel ^c   Flores, Gonzalo ^a   Guevara, Jorge ^c  

^a BENEMÉRITA UNIVERSIDAD AUTÓNOMA DE PUEBLA   (Mexico)

^b NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^d INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

Author keywords

Alzheimer; Animal models; Dendritic spine; Dorsal hippocampus; Hyperglycemia; Spatial memory

Indexed keywords

AMYLOID BETA PROTEIN[25-35];

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DENDRITIC SPINE; HIPPOCAMPAL CA1 REGION; HIPPOCAMPUS; HYPERGLYCEMIA; MALE; MORRIS WATER MAZE TEST; NERVE DEGENERATION; NONHUMAN; PYRAMIDAL NERVE CELL; RAT; SPATIAL LEARNING; SPATIAL MEMORY; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS;

EID: 84908054779     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.21770     Document Type: Article

References (113)

1. Agrawal R, Tyagi E, Shukla R, Nath C. 2009. A study of brain insulin receptors, AChE activity and oxidative stress in rat model of ICV STZ induced dementia. Neuropharmacology 56:779-787.
2. Alcántara-González F, Gamboa C, de la Cruz F, Zamudio S, Flores G. 2012. Combined administration of cerebrolyisin and donepezil induces plastic changes in medial prefrontal cortex and dentate gyrus in aged mice. Synapse 66:938-949.
3. Alquicer G, Morales-Medina JC, Quirion R, Flores G. 2008. Postweaning social isolation enhances morphological changes in the neonatal ventral hippocampal lesion rat model of psychosis. J Chem Neuroanat 35:179-187.
4. Arluison M, Quignon M, Nguyen P, Thorens B, Leloup C, Penicaud L. 2004. Distribution and anatomical localization of the glucose transporter 2 (GLUT2) in the adult rat brain an immunohistochemical study. J Chem Neuroanat 28:117-136.
5. Arvanitakis Z, Wilson RS, Bienias JL, Evans DA, Bennett DA. 2004. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol 61:661-666.
6. Barbaccia ML, Chuang DM, Costa E. 1982. Is insulin a neuromodulator? Adv Biochem Psychopharmacol 33:511-518.
7. Baydas G, Nedzvetskii VS, Nerush PA, Kirichenko SV, Yoldas T. 2003. Altered expression of NCAM in hippocampus and cortex may underlie memory and learning deficits in rats with streptozotocin-induced diabetes mellitus. Life Sci 73:1907-1916.
8. Beauquis J, Roig P, De Nicola AF, Saravia F. 2010. Short-term environmental enrichment enhances adult neurogenesis, vascular network and dendritic complexity in the hippocampus of type 1 diabetic mice. PLoS One 5:e13993.
9. Blokland A, Jolles J. 1993. Spatial learning deficit and reduced hippocampal ChAT activity in rats after an ICV injection of streptozotocin. Pharmacol Biochem Behav 44:491-494.
10. Blondel O, Portha B. 1989. Early appearance of in vivo insulin resistance in adult streptozotocin-injected rats. Diabete Metab 15:382-387.
11. Bolzán AD, Bianchi MS. 2002. Genotoxicity of streptozotocin. Mutat Res 512:121-134.
12. Boyd FT, Clarke DW, Raizada MK. 1986. Insulin inhibits specific norepinephrine uptake in neuronal cultures from rat brain. Brain Res 398:1-5.
13. Braun SM, Jessberger S. 2014. Review: Adult neurogenesis and its role in neuropsychiatric disease, brain repair and normal brain function. Neuropathol Appl Neurobiol 40:3-12.
14. Bringas ME, Carvajal-Flores FN, López-Ramírez TA, Atzori M, Flores G. 2013. Rearrangement of the dendritic morphology in limbic regions and altered exploratory behavior in a rat model of autism spectrum disorder. Neuroscience 241:170-187.
15. Buchsbaum MS, Kesslak JP, Lynch G, Chui H, Wu J, Sicotte N, Hazlett E, Teng E, Cotman CW. 1991. Temporal and hippocampal metabolic rate during an olfactory memory task assessed by positron emission tomography in patients with dementia of the Alzheimer type and controls. Preliminary studies. Arch Gen Psychiatry 48:840-847.
16. Butterfield DA, Boyd-Kimball D. 2005. The critical role of methionine 35 in Alzheimer's amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity. Biochim Biophys Acta 1703:149-156.
17. Carrillo-Mora P, Méndez-Cuesta LA, Pérez-De La Cruz V, Fortoul-van Der Goes TI, Santamaría A. 2010. Protective effect of systemic L-kynurenine and probenecid administration on behavioral and morphological alterations induced by toxic soluble amyloid beta (25-35) in rat hippocampus. Behav Brain Res 210:240-250.
18. Chang SW, Hu FR, Lin LL. 2001. Effects of contact lenses on corneal endothelium-A morphological and functional study. Ophthalmologica 215:197-203.
19. Chen Z, Zhong C. 2013. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: Implications for diagnostic and therapeutic strategies. Prog Neurobiol 108:21-43.
20. Cheng G, Whitehead SN, Hachinski V, Cechetto DF. 2006. Effects of pyrrolidine dithiocarbamate on beta-amyloid (25-35)-induced inflammatory responses and memory deficits in the rat. Neurobiol Dis 23:140-151.
21. Cheng L, Yin WJ, Zhang JF, Qi JS. 2009. Amyloid beta-protein fragments 25-35 and 31-35 potentiate long-term depression in hippocampal CA1 region of rats in vivo. Synapse 63:206-214.
22. Croce N, Dinallo V, Ricci V, Federici G, Caltagirone C, Bernardini S, Angelucci F. 2011. Neuroprotective effect of neuropeptide Y against β-amyloid 25-35 toxicity in SH-SY5Y neuroblastoma cells is associated with increased neurotrophin production. Neurodegener Dis 8:300-309.
23. Cuevas E, Limón D, Pérez-Severiano F, Díaz A, Ortega L, Zenteno E, Guevara J. 2009. Antioxidant effects of epicatechin on the hippocampal toxicity caused by amyloid-beta 25-35 in rats. Eur J Pharmacol 616:122-127.
24. de la Monte SM. 2012. Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease. Curr Alzheimer Res 9:35-66.
25. Delobette S, Privat A, Maurice T. 1997. In vitro aggregation facilities beta-amyloid peptide-(25-35) induce amnesia in the rat. Eur J Parmacol 319:1-4.
26. Di Luca D, Ruts L, Gardoni F, Cattabeni F, Biessels GJ, Gispen WH. 1999. NMDA receptor subunits are modified transcriptionally and post-translationally in the brain of streptozotocin-diabetic rats. Diabetologia 42:693-701.
27. Diaz A, Limon D, Chávez R, Zenteno E, Guevara J. 2012. Aβ25-35 injection into the temporal cortex induces chronic inflammation that contributes to neurodegeneration and spatial memory impairment in rats. J Alzheimers Dis 30:505-522.
28. Diaz A, Rojas K, Espinosa B, Chávez R, Zenteno E, Limón D, Guevara J. 2014. Aminoguanidine treatment ameliorates inflammatory responses and memory impairment induced by amyloid-beta 25-35 injection in rats. Neuropeptides 48:153-159.
29. Dickstein DL, Weaver CM, Luebke JI, Hof PR. 2013. Dendritic spine changes associated with normal aging. Neuroscience 251:21-32.
30. Doré S, Kar S, Quirion R. 1997. Insulin-like growth factor I protects and rescues hippocampal neurons against beta-amyloid- and human amylin-induced toxicity. Proc Natl Acad Sci USA 94:4772-4777.
31. Duara R, Loewenstein DA, Potter E, Appel J, Greig MT, Urs R, Shen Q, Raj A, Small B, Barker W, Schofield E, Wu Y, Potter H. 2008. Medial temporal lobe atrophy on MRI scans and the diagnosis of Alzheimer disease. Neurology 71:1986-1992.
32. Duarte AI, Moreira PI, Oliveira CR. 2012. Insulin in central nervous system: More than just a peripheral hormone. J Aging Res 2012:1-21.
33. Duyckaerts C. 2004. Looking for the link between plaques and tangles. Neurobiol. Aging 25:735-739.
34. Duyckaerts C, Uchihara T, Seilhean D, He Y, Hauw J J. 1997. Dissociation of Alzheimer type pathology in a disconnected piece of cortex. Acta Neuropathol 93:501-507.
35. Fiala A, Spall T, Diegelmann S, Eisermann B, Sachse S, Devaud JM, Buchner E, Galizia CG. 2002. Genetically expressed cameleon in Drosophila melanogaster is used to visualize olfactory information in projection neurons. Curr Biol 12:1877-1884.
36. Flores G, Alquicer G, Silva-Gomez AB, Zaldivar G, Stewart J, Quirion R, Srivastava LK. 2005. Alterations in dendritic morphology of prefrontal cortical and nucleus accumbens neurons in post-pubertal rats after neonatal excitotoxic lesions of the ventral hippocampus. Neuroscience 133:463-470.
37. Flores G, Negrete-Díaz JV, Carrión M, Andrade-Talavera Y, Bello SA, Sihra TS, Rodríguez-Moreno A. 2012. Excitatory amino acids in neurological and neurodegenerative disorders. In: D'Mello JPF, editor. Amino acids in human nutrition and health. Chapter 26. Wallingford, UK: Editorial CAB International. p 427-453.
38. Foster K, Margraf R, Turner D. 2008. NADH hyperoxidation correlates with enhanced susceptibility of aged rats to hypoxia. Neurobiol Aging 29:598-613.
39. Freude S, Schilbach K, Schubert M. 2009. The role of IGF-1 receptor and insulin receptor signaling for the pathogenesis of Alzheimer's disease: From model organisms to human disease. Curr Alzheimer Res 6:213-223.
40. Gagné J, Milot M, Gélinas S, Lahsaïni A, Trudeau F, Martinoli MG, Massicotte G. 1997. Binding properties of glutamate receptors in streptozotocin-induced diabetes in rats. Diabetes 46:841-846.
41. Gardoni F, Kamal A, Bellone C, Biessels GJ, Ramakers GM, Cattabeni F, Gispen WH, M. Di Luca M. 2002. Effects of streptozotocin-diabetes on the hippocampal NMDA receptor complex in rats. J Neurochem 80:438-447.
42. Gibb R, Kolb B. 1998. A method for vibratome sectioning of Golgi-Cox stained whole rat brain. J Neurosci Methods 79:1-4.
43. Gispen WH, Biessels GJ. 2000. Cognition and synaptic plasticity in diabetes mellitus. Trend Neurosci 23:542-549.
44. Grossman AW, Churchill JD, McKinney BC, Kodish IM, Otte SL, Greenough WT 2003. Experience effects on brain development: Possible contributions to psychopathology. J Child Psychol Psychiatry 44:33-63.
45. Gruden MA, Davudova TB, Malisauskas M, Zamotin VV, Sewell RD, Voskresenskaya NI, Kostanyan IA, Sherstnev VV, Morozova-Roche LA. 2004. Autoimmune responses to amyloid structures of Abeta(25-35) peptide and human lysozyme in the serum of patients with progressive Alzheimer's disease. Dement Geriatr Cogn Disord 18:165-171.
46. Gulyaeva N, Stepanichev M. 2010. Abeta(25-35) as proxyholder for amyloidogenic peptides: In vivo evidence. Exp Neurol 222:6-9.
47. Haider S, Ahmed S, Tabassum S, Memon Z, Ikram M, Haleem DJ. 2013. Streptozotocin-induced insulin deficiency leads to development of behavioral deficits in rats. Acta Neurol Belg 113:35-41.
48. Hardy J, Selkoe DJ. 2002. The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 298:962-964.
49. Hawkins BT, Ocheltree SM, Norwood KM, Egleton RD. 2007. Decreased blood-brain barrier permeability to fluorescein in streptozotocin-treated rats. Neurosci Lett 411:1-5.
50. Heiss WD, Szelies B, Kessler J, Herholz K. 1991. Abnormalities of energy metabolism in Alzheimer's disease studied with PET. Ann NY Acad Sci 640:65-71.
51. Hyman BT, Van Hoesen GW, Damasio AR, Barnes CL. 1984. Alzheimer's disease: Cell-specific pathology isolates the hippocampal formation. Science 225:1168-1170.
52. Iqbal K, Flory M, Khatoon S, Soininen H, Pirttila T, Lehtovirta M, Alafuzoff I, Blennow K, Andreasen N, Vanmechelen E, Grundke-Iqbal I. 2005. Subgroups of Alzheimer's disease based on cerebrospinal fluid molecular markers. Ann Neurol 58:748-757.
53. Jolivalt CG, Hurford R, Lee CA, Dumaop W, Rockenstein E, Masliah E. 2010. Type 1diabetes exaggerates features of Alzheimer's disease in APP transgenic mice. Exp Neurol 223:422-431.
54. Joshi S, Morley JE. 2006. Cognitive impairment. Med Clin North Am 90:769-787.
55. Juárez I, Gratton A, Flores G. 2008. Ontogeny of altered dendritic morphology in the rat prefrontal cortex, hippocampus and nucleus accumbens following Caesarean delivery and birth anoxia. J Comp Neurol 507:1734-1747.
56. Juárez I, González DJ, Mena R, Flores G. 2011. The chronic administration of cerebrolysin induces plastic changes in the prefrontal cortex and dentate gyrus in aged mice. Synapse 65:1128-1135.
57. Junnila RK, List EO, Berryman DE, Murrey JW, Kopchick JJ. 2013. The GH/IGF-1 axis in ageing and longevity. Nat Rev Endocrinol 9:366-376.
58. Kalb RG. 1994. Regulation of motor neuron dendrite growth by NMDA receptor activation. Development 120:3063-3071.
59. Kaminsky YG, Marlatt MW, Smith MA, Kosenko EA. 2010. Subcellular and metabolic examination of amyloid-beta peptides in Alzheimer disease pathogenesis: Evidence for Abeta(25-35). Exp Neurol 221:26-37.
60. Kar S, Poirier P, Guevara J, Dea D, Hawkes C, Robitaille Y, Quirion R. 2006. Cellular distribution of insulin-like growth factor-II/mannose-6-phosphate receptor in normal human brain and its alteration in Alzheimer's disease pathology. Neurobiol Aging 27:199-210.
61. Kolb B, Whishaw IQ.1998. Brain plasticity and behavior. Annu Rev Psychol 49:43-64.
62. Kolb B, Forgie M, Gibb R, Gorny G, Rowntree S. 1998. Age, experience and the changing brain. Neurosci Biobehav Rev 22:143-159.
63. Kubo T, Nishimura S, Kumagae Y, Kaneko I. 2002. In vivo conversion of racemized beta-amyloid ([D-Ser 26] A beta 1-40) to truncated and toxic fragments ([D-Ser26] A beta 25-35/40) and fragment presence in the brains of Alzheimer's patients. J Neurosci Res 70:474-483.
64. Leibson C, Rocca W, Hanson V, Cha R, Kokmen E, O'Brien P, Palumbo P. 1997. Risk of dementia among persons with diabetes mellitus: A population-based cohort study. Am J Epidemiol 145:301-308.
65. Limón ID, Díaz A, Mendieta L, Chamorro G, Espinosa B, Zenteno E, Guevara J. 2009. Amyloid-beta 25-35 impairs memory and increases NO in the temporal cortex of rats. Neurosci Res 63:129-137.
66. Liu Y, Liu F, Grundke-Iqbal I, Iqbal K, Gong CX. 2009. Brain glucose transporters, O-GlcNAcylation and phosphorylation of tau in diabetes and Alzheimer's disease. J Neurochem 111:242-249.
67. Liu Y, Liu F, Grundke-Iqbal I, Iqbal K, Gong CX. 2011. Deficient brain insulin signalling pathway in Alzheimer's disease and diabetes. J Pathol 225:54-62.
68. Lupien SB, Bluhm EJ, Ishii DN. 2003. Systemic insulin-like growth factor-I administration prevents cognitive impairment in diabetic rats, and brain IGF regulates learning/memory in normal adult rats. J Neurosci Res 74:512-523.
69. Malone JI, Hanna S, Saporta S, Mervis RF, Park CR, Chong L, Diamond DM. 2008. Hyperglycemia not hypoglycemia alters neuronal dendrites and impairs spatial memory. Pediatr Diabetes 9:531-539.
70. Martínez-Tellez R, Gómez-Villalobos Mde J, Flores G. 2005. Alteration in dendritic morphology of cortical neurons in rats with diabetes mellitus induced by streptozotocin. Brain Res 1048:108-115.
71. Martínez-Tellez RI, Hernández-Torres E, Gamboa C, Flores G. 2009. Prenatal stress alters spine density and dendritic length of nucleus accumbens and hippocampus neurons in rat offspring. Synapse 63:794-804.
72. Matthew WH, Walter C, Cancellaro LA, Hamdy RC. 1994. Impact of psychiatric evaluation on patients in geriatric evaluation and management units. J Tenn Med Assoc 87:329-331.
73. Maurice T, Lockhart BP, Privat A. 1996. Amnesia induced in mice by centrally administered b-amyloid peptides involves cholinergic dysfunction. Brain Res 706:181-193.
74. McAllister A.K. 2000. Cellular and molecular mechanisms of dendrite growth. Cereb Cortex 10:963-973.
75. McAllister AK, Stevens CF. 2000. Nonsaturation of AMPA and NMDA receptors at hippocampal synapses. Proc Natl Acad Sci USA 97:6173-6178.
76. McEwen BS, Magariños AM, Reagan LP. 2002. Studies of hormone action in the hippocampal formation: possible relevance to depression and diabetes. J Psychosom Res. 53:883-890.
77. McGeer PL, McGeer EG. 2006. NSAIDs and Alzheimer disease: Epidemiological, animal model and clinical studies. Neurobiol Aging 28:639-647.
78. Morris R. 1984. Development of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 11:47-60.
79. Mosconi L. 2005. Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD. Eur J Nucl Med Mol Imaging 32:486-510.
80. Musazzi L, Treccani G, Mallei A, Popoli M. 2013. The action of antidepressants on the glutamate system: Regulation of glutamate release and glutamate receptors. Biol Psychiatry 73:1180-1188.
81. Novák M. 1994. Truncated tau protein as a new marker for Alzheimer's disease. Acta Virol 38:173-189.
82. Ozawa Y, Kurihara T, Sasaki M, Ban N, Yuki K, Kubota S, Tsubota K. 2011. Neural degeneration in the retina of the streptozotocin-induced type 1 diabetes model. Exp Diabetes Res 2011:1-7, ID 108328.
83. Panizzutti R, Scoriels L, Avellar M. The co-agonist site of NMDA-glutamate receptors: A novel therapeutic target for age-related cognitive decline. Curr Pharm Des, Epub ahead of print.
84. Paxinos G, Watson C. 1998. The rat brain in stereotaxic coordinates, 4th ed. London, UK: Academic Press.
85. Pérez-Severiano F, Salvatierra-Sanchez R, Rodriguez-Perez M, Cuevas-Martinez EY, Guevara J, Limon D, Maldonado PD, Medina-Campos ON, Pedraza-Chaverri J, Santamaria A. 2004. S-allylcysteine prevents amyloid-beta peptide-induced oxidative stress in rat hippocampus and ameliorates learning deficits. Eur J Pharmacol 489:197-202.
86. Pike CJ, Walencewicz AJ, Glabe CG, Cotman CW. 1991. In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res 563:311-318.
87. Planel E, Tatebayashi Y, Miyasaka T, Liu L, Wang L, Herman M, Yu WH, Luchsinger JA, Wadzinski B, Duff KE, Takashima A. 2007. Insulin dysfunction induces in vivo tau hyperphosphorylation through distinct mechanisms. J Neurosci 27:13635-13648.
88. Roberts EL, Jr, Chih CP. 1995. Age-related alterations in energy metabolism contribute to the increased vulnerability of the aging brain to anoxic damage. Brain Res 678:83-90.
89. Sasaki S, Inoguchi T. 2012. The role of oxidative stress in the pathogenesis of diabetic vascular complications. Diabetes Metab J 36:256-261.
90. Sato N, Takeda S, Uchio-Yamada K, Ueda H, Fujisawa T, Rakugi H, Morishita R. 2011. Role of insulin signaling in the interaction between Alzheimer disease and diabetes mellitus: A missing link to therapeutic potential. Curr Aging Sci 4:118-127.
91. Selkoe DJ. 1997. Alzheimer's disease: from genes to pathogenesis. Am J Psychiatry 154:1198.
92. Shan W, Yoshida M, Wu XR, Huntley GW, Colman DR. 2002. Neural (N-) cadherin, a synaptic adhesion molecule, is induced in hippocampal mossy fiber axonal sprouts by seizure. J Neurosci Res 69:292-304.
93. Sholl DA. 1953. Dendritic organization in the neurons of the visual and motor cortices of the cat. J Anat 87:387-406.
94. Silva-Gómez AB, Rojas D, Juárez I, Flores G. 2003. Decreased dendritic spine density on prefrontal cortical and hippocampal pyramidal neurons in postweaning social isolation rats. Brain Res 983:128-136.
95. Sims-Robinson C, Kim B, Rosko A, Feldman EL. 2010. How does diabetes accelerate Alzheimer's disease pathology? Nat Rev Neurol 6:551-559.
96. Snyder EM, Nong Y, Almeida CG, Paul S, Moran T, Choi EY, Nairn AC, Salter MW, Lombroso PJ, Gouras GK, Greengard, P. 2005. Regulation of NMDA receptor trafficking by amyloid-beta. Nat Neurosci 8:1051-1058.
97. Solis O, Vázquez-Roque RA, Camacho-Abrego I, Gamboa C, De La Cruz F, Zamudio S, Flores G. 2009. Decreased dendritic spine density of neurons of the prefrontal cortex and nucleus accumbens and enhanced amphetamine sensitivity in postpubertal rats after a neonatal amygdala lesion. Synapse 63:1143-1153.
98. Song C, Zhang Y, Dong Y. 2013. Acute and subacute IL-1β administrations differentially modulate neuroimmune and neurotrophic systems: Possible implications for neuroprotection and neurodegeneration. J Neuroinflammation 10:59.
99. Squire LR. 1986. Mechanisms of memory. Science 232:1612-1619.
100. Stepanichev MY, Zdobnova IM, Zarubenko II, Moiseeva YV, Lazareva NA, Onufriev MV. 2004. Amyloid-b(25-35)-induced memory impairments correlated with cell loss in rat hippocampus. Physiol Behav 80:247-655.
101. Storey E1, Kinsella GJ, Slavin MJ. 2001. The neuropsychological diagnosis of Alzheimer's disease. J Alzheimers Dis 3:261-285.
102. Szkudelski T. 2001. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res 50:537-546.
103. Tan XJ, Dai YB, Wu WF, Kim HJ, Barros RP, Richardson TI, Yaden BC, Warner M, Mckinzie DL, Krishnan V, Gustafsson JÅ. 2012. Reduction of dendritic spines and elevation of GABAergic signaling in the brains of mice treated with an estrogen receptor β ligand. Proc Natl Acad Sci USA 109:1708-1712.
104. Teng Y, Zhang MQ, Wang W, Liu LT, Zhou LM, Miao SK, Wan LH. 2014. Compound danshen tablet ameliorated aβ25-35-induced spatial memory impairment in mice via rescuing imbalance between cytokines and neurotrophins. BMC Complement Altern Med 14:23.
105. Thal DR, Rub U, Orantes M, Braak H. 2002. Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791-1800.
106. Turner PR, O'Connor K, Tate WP, Abraham WC. 2003. Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory. Prog Neurobiol 70:1-32.
107. Vogel AM, Yoon J, Das A. 1995. Mutational analysis of a conserved motif of Agrobacterium tumefaciens VirD2. Nucleic Acids Res 23:4087-4091.
108. Wallenstein GV, Eichenbaum H, Hasselmo ME. 1998. The hippocampus as an associator of discontinuous events. Trends Neurosci 21:317-323.
109. Watson GS, Craft S. 2003. The role of insulin resistance in the pathogenesis of Alzheimer's disease: Implications for treatment. CNS Drugs 17:27-45.
110. Wisniewski T1, Ghiso J, Frangione B. 1997. Biology of A beta amyloid in Alzheimer's disease. Neurobiol Dis 4:313-328.
111. Yang Y, Ma D, Wang Y, Jiang T, Hu S, Zhang M, Yu X, Gong CX. 2013. Intranasal insulin ameliorates tau hyperphosphorylation in a rat model of type 2 diabetes. J Alzheimers Dis 33:329-338.
112. Yu W, Lu B. 2012. Synapses and dendritic spines as pathogenic targets in Alzheimer's disease. Neural Plast 2012:247150.
113. Zhang HT1, Li LY, Zou XL, Song XB, Hu YL, Feng ZT, Wang TT. 2007. Immunohistochemical distribution of NGF, BDNF, NT-3, and NT-4 in adult rhesus monkey brains. J Histochem Cytochem 55:1-19.